市场调查报告书
商品编码
1615220
益生菌菌株的全球市场:成长,未来展望,竞争分析 (2024年~2032年)Probiotic Strains Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032 |
益生菌菌株市场围绕着特定益生菌菌株的商业化和应用。当以适当的量施用时,这些微生物会为宿主带来健康益处。从历史上看,益生菌主要与优格和其他发酵食品有关。然而,随着科学认识的增加,针对特定健康问题的特定菌株的分离已成为一个蓬勃发展的市场。由于健康意识的提高和应用的扩大,益生菌菌株市场预计从 2024 年到 2032 年将以 7.8% 的复合年增长率成长。
市场驱动力:肠道健康意识不断增强
推动益生菌菌株市场的主要因素之一是人们越来越意识到肠道健康在整体健康中的重要作用。有句话说: "一切疾病都始于肠道" 。现代科学越来越支持这一点,肠道健康不仅与消化系统疾病有关,还与更广泛的健康问题有关,从心理健康到免疫系统功能。例如,《精神药理学》杂誌发表的研究表明,乳酸菌和双歧桿菌等益生菌菌株可以产生和输送γ-氨基丁酸(GABA)等神经活性物质,对情绪有直接影响。
市场机会:营养补充品和化妆品领域的扩张
益生菌菌株在营养保健品和化妆品领域正在迅速成长。人们不断寻求天然的健康解决方案,因此益生菌菌株越来越多地被纳入营养补充剂中。此外,美容护肤产业不再只关注美观,而是强调整体皮肤健康。 《国际女性皮肤病学杂誌》上发表的一篇论文强调,益生菌可能成为皮肤护理领域的潜在游戏规则改变者,解决从痤疮到衰老等一系列问题,并为市场成长提供主要途径。
市场约束:严格的监理架构
然而,益生菌株市场并非一帆风顺。一个关键的抑制因素是围绕健康声明的严格监管环境。在许多地区,产品需要经过严格的测试和验证过程才能贴上含有益生菌的标籤并声称具有相关的健康益处。例如,欧洲食品安全局(EFSA)对益生菌相关的健康声明特别严格,由于缺乏证据而拒绝了其中许多声明。
市场挑战:菌株稳定性与生存能力
除了监管方面的挑战外,益生菌菌株的稳定性和活力还面临具体的挑战。确保这些菌株存活并持续有效直至到达消费者手中绝非易事。温度、pH 值和氧气水平等因素会极大地影响益生菌菌株的活力。正如《世界胃肠病学杂誌》所引用的那样,许多产品经过测试,发现其所含的活细菌远低于规定的水平,或者根本没有,这凸显了向最终消费者提供强大而有效的产品的关键挑战。
按类型细分
益生菌菌株市场主要按类型细分,包括乳酸桿菌、鼠李糖乳桿菌 GG 和双歧桿菌等主要菌株。 2023年,嗜酸乳桿菌在收入方面占据市场主导地位,这主要是由于其在治疗从乳糖不耐症到某些皮肤病等疾病的应用。然而,鼠李糖乳桿菌 GG 片段显示出最高的平均年增长率 (CAGR)。该菌株已广受欢迎,因为经过充分研究,它可以有效治疗和预防许多疾病,特别是胃肠道感染和抗生素相关性腹泻。
依形状细分
从形态来分析市场,益生菌市场分为干型和液体型。从历史上看,干燥领域在 2023 年占据了很大的销售额。干燥益生菌主要为胶囊或粉末形式,与液体相比,保质期更长,更容易储存,并且需要更少的运输。然而,预计 2024 年至 2032 年液体类型的复合年增长率将显着。这种成长是由康普茶、克菲尔和益生菌注射液等饮用益生菌的需求不断增长所推动的。
区域洞察
从地区来看,北美地区成为 2023 年最大的收入贡献者。高度认可、研发方面的大量投资以及成熟的营养保健品和食品和饮料行业等因素支持了该地区市场的成功。然而,预计 2024 年至 2032 年亚太地区的复合年增长率最高。这一趋势是由中国和印度等国家的爆炸性增长推动的,这些国家的特征是人口快速城市化,可支配收入不断增加,对健康和保健产品的偏好日益增强。
竞争趋势
在竞争格局中,Hansen Holding A/S、Probi、Aumgene Bioscience、Virchow Biotech Private Limited、Merck KGaA、I. du Pont de Nemours and Company、Koninklijke DSM NV、Ganeden、Lesaffre、Essum AB、Vario Dairy、 BioGaia 、森永乳业有限公司、Snowboard Dairy Co., Ltd.、达能、Kerry Plc、Culturelle、Urex生物技术等公司是领跑者。 2023年,这些公司采取了从併购到大规模研发投资的策略来确保市场主导地位。例如,杜邦公司收购健康增强产品显示其打算加强在益生菌领域的地位。市场参与者也在深入研究,以发现具有独特健康益处的新菌株,确保稳定推出满足不断变化的消费者需求的产品。
本报告回答的主要问题
影响益生菌菌株市场成长的关键微观和宏观环境因素有哪些?
在目前和预测期间内,产品领域和地区的主要投资领域是什么?
估计/预测/市场预测(直到 2032 年)
哪个细分市场在预测期间内复合年增长率最快?
哪个细分市场拥有较大的市场占有率,为什么?
低收入和中等收入国家是否正在投资益生菌菌株市场?
益生菌菌株市场中最大的区域市场是哪一个?
亚太、拉丁美洲、中东/非洲等新兴市场的市场趋势与趋势如何?
推动益生菌菌株市场成长的主要趋势是什么?
主要竞争对手是什么以及他们提高在全球益生菌菌株市场的影响力的关键策略是什么?
The probiotic strains market revolves around the commercialization and application of specific strains of probiotics. These microorganisms, when administered in adequate amounts, confer health benefits to the host. Historically, probiotics were primarily associated with yogurt and other fermented foods. However, as scientific understanding deepened, the isolation of specific strains to target particular health concerns has become a burgeoning market. Probiotic Strains Market is estimated to grow at a CAGR of 7.8% from 2024 to 2032, driven by rising health consciousness and expanding applications.
Market Driver - Rising Awareness of Gut Health
One of the primary drivers propelling the Probiotic Strains Market is the mounting awareness of the critical role of gut health in overall well-being. There's an adage, 'All diseases begin in the gut.' Modern science increasingly supports this, associating gut health with not only digestive disorders but also with broader health issues, from mental health to immune system functionality. For instance, Psychopharmacology published a study showing that probiotic strains like Lactobacillus and Bifidobacterium can produce and deliver neuroactive substances such as gamma-aminobutyric acid (GABA), which have direct effects on mood.
Market Opportunity - Expansion in Nutraceutical and Cosmetic Sectors
There's a burgeoning opportunity for probiotic strains in the nutraceutical and cosmetic sectors. People are continually seeking natural solutions to health concerns, and as a result, the incorporation of probiotic strains into dietary supplements is on the rise. Furthermore, the beauty and skincare industry is no longer just about aesthetics; it's increasingly about overall skin health. A publication in the International Journal of Women's Dermatology highlighted that probiotics could be potential game-changers in skincare, combating issues from acne to aging, and presenting a massive avenue for market growth.
Market Restraint - Stringent Regulatory Frameworks
However, not everything is smooth sailing for the Probiotic Strains Market. A significant restraint is the stringent regulatory landscape surrounding health claims. In many regions, for a product to be labeled as containing probiotics and to tout associated health benefits, there are rigorous testing and validation processes. The European Food Safety Authority (EFSA), for example, has been particularly strict about health claims related to probiotics, rejecting many due to insufficient evidence.
Market Challenge - Stability and Viability of Strains
Beyond regulatory challenges, there's a tangible challenge related to the stability and viability of probiotic strains. Ensuring that these strains remain alive and effective when reaching the consumer is no small feat. Factors such as temperature, pH, and oxygen levels can dramatically impact the viability of probiotic strains. As cited by The World Journal of Gastroenterology, many products, when tested, contain far fewer live organisms than stated, or sometimes none at all, highlighting the critical challenge of delivering a potent and efficacious product to the end consumer.
Segmentation by Type
The probiotic strains market is prominently segmented by type, with key strains including Lactobacillus acidophilus, Lactobacillus rhamnoses GG, Bifidobacterium bifidum, among others. In 2023, Lactobacillus acidophilus dominated the market in terms of revenue, primarily due to its broad-spectrum application in treating conditions ranging from lactose intolerance to certain skin disorders. However, the Lactobacillus rhamnoses GG segment exhibited the highest Compound Annual Growth Rate (CAGR). This strain has gained traction because of its well-researched benefits and efficacy in treating and preventing a plethora of conditions, notably gastrointestinal infections and antibiotic-associated diarrhea.
Segmentation by Form
On analyzing the market by form, the probiotics market bifurcates into dry and liquid forms. Historically, the dry segment held the lion's share of the revenue in 2023. Dry probiotics, primarily in capsule or powdered forms, offer longer shelf-life, easy storage, and hassle-free transportation compared to their liquid counterparts. However, the liquid form segment is anticipated to witness a remarkable CAGR from 2024 to 2032. This growth can be attributed to the increasing demand for drinkable probiotics like kombucha, kefir, and probiotic shots, driven by consumers' inclination toward ready-to-drink health beverages.
Regional Insights
Geographically, the North American region emerged as the largest revenue contributor in 2023. Factors such as high awareness levels, significant investments in R&D, and the presence of well-established nutraceutical and food & beverage industries underpin the market's success in this region. Nevertheless, the Asia-Pacific region is expected to register the highest CAGR from 2024 to 2032. The explosive growth in countries like China and India, characterized by rapidly urbanizing populations with increasing disposable incomes and a growing penchant for health and wellness products, is driving this trend.
Competitive Trends
In the competitive landscape, companies like Hansen Holding A/S, Probi, Aumgene Bioscience, Virchow Biotech Private Limited, Merck KGaA, I. du Pont de Nemours and Company, Koninklijke DSM N.V., Ganeden, Lesaffre, Essum AB, Valio Dairy, BioGaia, Morinaga Milk Industry Co., Ltd., Snow Board Milk Products Co., Ltd., Danone, Kerry Plc, Culturelle, Urex Biotech are some of the front runners. In 2023, these players adopted strategies ranging from mergers and acquisitions to extensive R&D investments to ensure market dominance. For instance, DuPont's acquisition of Health Enhancement Products signified its intent to bolster its position in the probiotics space. Market players are also delving deep into research to uncover novel strains with unique health benefits, ensuring a steady stream of product launches that cater to evolving consumer demands.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Probiotic Strains market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Probiotic Strains market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Type
Form
End-Use
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Probiotic Strains market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Probiotic Strains market?
Which is the largest regional market for Probiotic Strains market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Probiotic Strains market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Probiotic Strains market worldwide?
FIG. 10Market Positioning of Key Probiotic Strains Market Players, 2023
FIG. 11Global Probiotic Strains Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032